Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00358995
Status:
COMPLETED
Last Update Posted:
2014-02-19
First Post:
2006-07-28
Brief Title:
A Cognitive Behavioral Therapy of Primary Obsessions in Obsessive Compulsive Disorder
Sponsor:
University of British Columbia
Organization:
University of British Columbia
Study Overview
Official Title:
A New Cognitive Behavioral Therapy to Target Distorted Appraisals Characteristic of Primary Obsessions in Obsessive Compulsive Disorder
Status:
COMPLETED
Status Verified Date:
2014-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A New Cognitive Behavioral Therapy to Target Distorted Appraisals Characteristic of Primary Obsessions in Obsessive Compulsive Disorder
Detailed Description:
Participants will be phone-screened to determine broad suitability and interest in being in the study as well as availability Following telephone screening participants will meet with a clinician who will administer a semi-structured interview to determine diagnostic status followed by a more specific standard semi-structured interview to measure symptom strength in those participants who meet diagnostic criteria of OCD primary obsessions Participants will then be invited to join the study Participants will be randomly assigned to either immediate treatment or delayed treatment three month delay Participants will then be again be randomly assigned to either Cognitive Behavior Therapy CBT or Stress Management Therapy SMT The delayed participants wait list control will be randomly assigned to either of the two active treatment groups in three months time Both active treatment conditions involve one hours individual treatment sessions for 12 consecutive weeks by one of the treating psychologists All participants will also be asked to complete a package of psychometric questionnaires before treatment Participants assigned to the delayed treatment condition will be asked to complete these questionnaires again before proceeding to treatment once they have completed the three month wait The participants will be re-evaluated at the end of treatment at six months after treatment and at one year after treatment using the same assessment procedure
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None